A Repurposed Duo: Empagliflozin-Metformin Triggers a Metabolic Crisis in Cervical Cancer by Disrupting the Acyl-CoA/CoA Ratio via Dual Inhibition of PPAT and CPT1A. Journal of Cancer Research Updates, [S. l.], v. 14, p. 247–265, 2025. DOI: 10.30683/1929-2279.2025.14.26. Disponível em: https://www.neoplasiaresearch.com/index.php/jcru/article/view/922. Acesso em: 19 apr. 2026.